Pamela Klein

Pamela Klein serves as an Independent Director on the Board of Directors for multiple organizations, including argenx, Frontier Medicines, ONA Therapeutics, Ysios Capital, Shasqi, and Patrys Limited. With extensive experience in oncology drug development and strategy as an Independent Biotech/Pharma Consultant at PMK BioResearch since 2008, Pamela Klein also held the role of Interim Chairperson at I-Mab Biopharma and served on the Board of Directors for F-star Therapeutics, Inc. A graduate of Loyola University Chicago Stritch School of Medicine with an M.D. in Oncology and Internal Medicine, Pamela Klein also holds a Bachelor's degree in Biology from California State University, Northridge.